VARICELLA-ZOSTER VIRUS
Clinical trials for VARICELLA-ZOSTER VIRUS explained in plain language.
Never miss a new study
Get alerted when new VARICELLA-ZOSTER VIRUS trials appear
Sign up with your email to follow new studies for VARICELLA-ZOSTER VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA shot aims to stop painful shingles outbreaks
⭐️ VACCINE ⭐️ OngoingThis study is testing a new experimental mRNA vaccine designed to prevent shingles, a painful rash caused by the reactivated chickenpox virus. It will involve about 300 healthy adults aged 40 and older who will receive two shots about two months apart. The main goals are to see h…
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE2 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 14:57 UTC
-
New mRNA tech takes aim at shingles in early human trial
⭐️ VACCINE ⭐️ OngoingThis is an early-stage study testing a new type of shingles vaccine that uses mRNA technology. It aims to see if the vaccine is safe and triggers a good immune response in 180 healthy adults aged 40 and older. Participants will receive two shots about two months apart, and resear…
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 11, 2026 14:52 UTC